Introduction {#sec1}
============

Lineage tracing is a powerful tool for studying tissue development, homeostasis, and disease, and has provided unprecedented insights into stem cell biology ([@bib11]). Previous lineage-tracing studies mostly relied on inducible Cre-estrogen receptor fusion protein (CreER)-expressing transgenic mice upon induction by tamoxifen. This inducible system was recently used for fate-mapping studies of mammary epithelial cells (MECs) under the physiological setting ([@bib12; @bib17; @bib19; @bib24; @bib25]). However, wider application of this approach is limited by several factors. First, the choice of specific inducible CreER-expressing lines is often limited, and generating new mouse lines for this purpose can be time consuming. Second, most *CreER* mice do not target MECs exclusively, and for breast cancer modeling studies, their activities outside of the mammary gland (MG) may lead to systematic deficiency or unwanted tumor induction in other tissues, which could limit their use for studying MECs. Third, administration of tamoxifen may interfere with development of hormone-dependent tumors (e.g., mammary tumors), as well as normal MG development ([@bib17]). Lastly, recent studies showed that the tamoxifen doses commonly used to induce Cre/lox recombination in mice might continue to label significant numbers of cells for weeks after tamoxifen treatment ([@bib16]) and that tamoxifen could change the behavior of stem cells ([@bib26]), both of which could affect interpretation of results from lineage-tracing experiments.

Adenovirus is a DNA virus, and it does not integrate into the host genome. It can infect both dividing and nondividing cells, leading to transient high-level protein expression ([@bib1]). Intraductal injection of adenovirus was previously shown to be an efficient way to transduce genes in MECs ([@bib18]). Cre-expressing adenovirus (*Ad-Cre*) under the control of the constitutive *CMV* promoter (*Ad-CMV-Cre*) has been successfully used to induce cancer development in multiple organs (e.g., lung, ovary, and bladder; \[[@bib5; @bib6; @bib15]\]). Recently, [@bib22] used cell-type-specific promoters and *Ad-Cre* to initiate small cell lung cancer development from different subsets of lung cells. We hypothesized that, similarly to the inducible CreER system, transient expression of Cre from adenoviral vectors could offer a temporal and spatial genetic-marking system for pulse-chase lineage-tracing studies in adult cells. In this study, we tested this approach in the MG by generating MEC lineage-specific *Ad-Cre* lines, and demonstrated that they can be used for MEC fate-mapping, gene loss-of-function, and cancer-induction studies in the native environment. This approach should also be suitable for lineage-tracing studies in other systems in which introduction of *Ad-Cre* is feasible.

Results and Discussion {#sec2}
======================

Genetic Marking of MECs by Intraductal Injection of *Ad-Cre* {#sec2.1}
------------------------------------------------------------

It was demonstrated previously that mammary epithelium could be effectively transduced in vivo by adenovirus via intraductal injection ([@bib18]). We performed this procedure successfully in MGs of both adult virgin ([Figure 1](#fig1){ref-type="fig"}A) and 3-week-old ([Figure 1](#fig1){ref-type="fig"}B) female mice. Since puberty in mice occurs at ∼4--6 weeks of age, this approach should allow us to introduce genetic changes into MECs during both pubertal development and adulthood. In pilot experiments, we injected *Ad-CMV-Cre* into \#4 MGs of a conditional Cre-reporter mouse line, *Rosa26-lsl-YFP* (*R26YFP*). Cre expression from adenovirus triggered the excision of a floxed *Stopper* cassette in the *R26YFP* knockin allele, leading to permanent genetic marking of the infected cells and their progeny by yellow fluorescent protein (YFP; [Figures 1](#fig1){ref-type="fig"}C and 1D). The labeling efficiency of MECs, as measured by the percentage of YFP^+^ cells 3 days after injection, ranged from 0.65% ± 0.05% to 19.23% ± 4.85%, corresponding to titers of *Ad-CMV-Cre* from 10^7^ to 10^9^ pfu/ml ([Figure 1](#fig1){ref-type="fig"}E). All major MEC subpopulations, including mature luminal cells (MLs, CD31^−^CD45^−^TER119^−^(Lin^−^)CD24^hi^CD29^+^CD61^−^), luminal progenitors (LPs, Lin^−^CD24^hi^CD29^+^CD61^+^), and basal cells (Lin^−^CD24^med^CD29^hi^), could be effectively labeled ([Figure 1](#fig1){ref-type="fig"}F). Only very minimal YFP-marked cells were detected in the stromal gate, which suggests that little viral leakage occurred, thus enabling us to study cell-autonomous effects in MECs ([Figure 1](#fig1){ref-type="fig"}F). Since the needle used for injection might have come in contact with skin surrounding the nipple, we performed immunofluorescence (IF) staining of tissues in this area. We only detected YFP^+^ cells in the mammary ducts directly adjacent to the skin, as well as a few YFP^+^ stromal cells; no skin cells were found to be YFP^+^ ([Figure S1](#app2){ref-type="sec"}A available online). Using flow cytometry and PCR for genomic DNA, we did not detect Cre-mediated excision in the *R26YFP* allele in tissues outside of the MG ([Figures S1](#app2){ref-type="sec"}B--S1D), further confirming the MEC specificity of this approach. Lastly, since it was reported that intratracheal administration of *Ad-Cre* to the mouse lung could lead to clearance of infected lung cells, possibly due to an immune response ([@bib14]), we checked mammary tissues at various time points after intraductal injection of *Ad-Cre*. We did not observe any significant inflammatory response ([Figure S1](#app2){ref-type="sec"}E), consistent with a previous study ([@bib18]).

To assess the transient expression nature of adenovirus in vivo, we measured the duration of adenovirus-mediated gene expression in MECs by intraductally injecting *CMV-GFP* adenovirus (*Ad-CMV-GFP*) into wild-type FVB females. We found that at day 2 postinjection, 14.77% ± 4.60% GFP^+^ cells were detected in the injected MGs; this number quickly dropped to 3.70% ± 1.48% at 1 week after injection, and to zero at 2 weeks postinjection ([Figure 1](#fig1){ref-type="fig"}G). We reason that Cre expression from the same adenoviral system should follow a similar kinetics and thus serves a similar purpose as the inducible *CreER* mice.

MEC Lineage Tracing Using Cell-Type-Specific *Ad-Cre* Lines {#sec2.2}
-----------------------------------------------------------

To target different MEC subsets, we generated lineage-specific *Ad-Cre* lines by using the same adenoviral backbone as *Ad-CMV-Cre* coupled with a cell-type-specific promoter to drive nlsCre (nls: nuclear localization sequence) expression. For the luminal lineage, we used the mouse *Keratin 8* (*K8*) promoter ([@bib25]) and generated *Ad-K8-nlsCre* virus. Three days after *Ad-K8-nlsCre* injection into *R26YFP* females, we found that *Ad-K8-nlsCre* specifically led to YFP labeling of luminal MECs ([Figure 2](#fig2){ref-type="fig"}Ab), including both MLs and LPs ([Figure 2](#fig2){ref-type="fig"}Ad). By IF staining of sorted YFP^+^ cells or MG sections from the injected *R26YFP* females, we confirmed that the YFP^+^ cells were exclusively K8^+^K14^−^ luminal cells ([Figures 2](#fig2){ref-type="fig"}C and [S2](#app2){ref-type="sec"}D). To test the long-term labeling efficiency, we chased *R26YFP* females injected with *Ad-K8-nlsCre* for 1.5 months. At this stage, we found that YFP^+^ cells could still be detected robustly and all YFP^+^ cells remained restricted to the luminal gate ([Figure 2](#fig2){ref-type="fig"}Af). A similar observation was made even when the injected mice were chased further to 6 months ([Figure S2](#app2){ref-type="sec"}A). These data suggest that the K8^+^ luminal lineage contains self-sustained, long-lived MECs. Next, *Ad-K8-nlsCre-*injected *R26YFP* females were bred to trigger alveolar differentiation. At midgestation, we found that *Ad-K8-nlsCre-*marked YFP^+^ luminal cells contributed to luminal cells in both lobules and main collecting ducts ([Figures 2](#fig2){ref-type="fig"}D and [S2](#app2){ref-type="sec"}B). A previous in vivo lineage-tracing study using *K8-CreERT2* mice showed that in adult MGs, the luminal and basal lineages were maintained by their own unipotent stem cells ([@bib25]). Although a more recent lineage-tracing study provided evidence for a contribution of bipotent basal stem cells to the luminal lineage in vivo, it also revealed long-lived LPs that could contribute to maintenance of the luminal lineage ([@bib17]). The results from our *Ad-K8-nlsCre* approach agreed with these findings, showing that the luminal lineage, including both ductal and alveolar luminal cells, could be self-sustained by luminal lineage-restricted stem cells or long-lived progenitors.

To mark the basal lineage, we used the human *Keratin 14* (*K14*) promoter to direct nlsCre expression via adenovirus (*Ad-K14-nlsCre*) ([@bib21]). By intraductally injecting *Ad-K14-nlsCre* into *R26YFP* females, we found that most YFP^+^ cells were restricted to the basal gate; however, a small population of YFP^+^ cells could also be detected in the luminal gate ([Figure 2](#fig2){ref-type="fig"}Bb). Upon a long-term chase (1.5 months), we found that *Ad-K14-nlsCre-*marked YFP^+^ basal and luminal cells were both maintained ([Figure 2](#fig2){ref-type="fig"}Bf). To determine the identities of the YFP^+^ cells, we sorted YFP^+^ cells in the luminal or basal gate from *R26YFP* females 3 days after *Ad-K14-nlsCre* injection, and stained them for K8 and K14. We found that YFP^+^ cells sorted from the basal gate were exclusively K8^−^K14^+^ basal cells ([Figure S2](#app2){ref-type="sec"}E). In contrast, the smaller subpopulation of YFP^+^ cells sorted from the luminal gate were entirely K8^+^K14^−^, suggesting that a small portion of luminal cells were indeed labeled by *Ad-K14-nlsCre* ([Figure S2](#app2){ref-type="sec"}F). Next, *R26YFP* females were marked by *Ad-K14-nlsCre* at the nulliparous stage and either remained virgins or went through pregnancy. By IF staining of their MG sections, we found that *Ad-K14-nlsCre-*marked basal cells contributed to both alveolar and ductal basal/myoepithelial cells ([Figures 2](#fig2){ref-type="fig"}E, 2F, and [S2](#app2){ref-type="sec"}C). A small portion of YFP^+^ MECs induced by *Ad-K14-nlsCre* also contributed to lobular and ductal luminal cells ([Figure 2](#fig2){ref-type="fig"}G). To determine the cellular origins of these labeled luminal cells, we performed a detailed clonal analysis ([Figures 2](#fig2){ref-type="fig"}H and [S2](#app2){ref-type="sec"}G--S2J). We counted YFP^+^ clones in the injected MGs at 3 days, 3 weeks, and 7 weeks after *Ad-K14-nlsCre* injection, and classified them into three categories: K14-only clones (K14^+^K8^−^), K8-only clones (K8^+^K14^−^), and mixed clones containing both cell types. We found that generally, K14^+^ clones and K8^+^ clones were labeled independently of each other ([Figures 2](#fig2){ref-type="fig"}H and [S2](#app2){ref-type="sec"}G). Upon a 7-week chase, ∼70% K14-only basal clones, 20% K8-only luminal clones, and 10% mixed clones were observed ([Figure S2](#app2){ref-type="sec"}G). These data, combined with those obtained from *Ad-K8-nlsCre-*based lineage tracing, suggest that the K14^+^ basal lineage is also self-sustained and may not contribute significantly to the luminal lineage in the short term. However, our data (e.g., showing the presence of mixed clones and a slight increase in the percentages of K8-only and mixed multicell clones upon a 7-week chase; [Figure 2](#fig2){ref-type="fig"}H) also do not exclude the possibility that rare K14^+^ basal MECs can make a long-term contribution to the luminal lineage under the physiological setting, as demonstrated recently ([@bib17]). Since the mixed clones we observed may also have resulted from the fusion of two independently labeled basal and luminal clones that were in a close proximity, three-dimensional analyses at much lower clonal densities will be required before we can precisely assess the cellular origin of these putative mixed clones.

IRS1 and IRS2 Are Essential for Maintaining the Basal Lineage {#sec2.3}
-------------------------------------------------------------

To determine whether lineage-specific *Ad-Cre* can be used to study the cell-autonomous function of genes or signaling pathways, we used *Ad-K8-nlsCre* and *Ad-K14-nlsCre* to study the role of insulin growth factor/insulin receptor substrate (IGF/IRS) signaling in adult MECs. During development, the IGF pathway is a primary mediator of the Growth Hormone pathway, which stimulates terminal end bud formation and ductal elongation ([@bib9; @bib10]). Intracellular transduction of IGF and Insulin signaling are both mediated by two adaptor proteins, IRS1 and IRS2, through tyrosine phosphorylation ([@bib4; @bib8]). Abnormal activation of IGF signaling is closely associated with increased breast cancer risk ([@bib3]).

Both IRS1 and IRS2 were previously shown to play important roles during embryonic MG development ([@bib2; @bib8]). Postnatally, both *Irs1* and *Irs2* null MGs are normal, possibly because they compensate for each other ([@bib2; @bib8]). We previously generated *Irs1/Irs2* double conditional knockout mice with the *R26YFP* reporter (*Irs1*^*L/L*^*;Irs2*^*L/L*^*;R26YFP*) and used *K14-Cre* and *MMTV-Cre* mouse lines to disrupt them in MECs ([Figure S3](#app2){ref-type="sec"}A). Although the MGs of these mice looked largely normal by both histological ([Figure S3](#app2){ref-type="sec"}B) and flow-cytometric ([Figure S3](#app2){ref-type="sec"}C) analyses, by characterizing the Lin^−^YFP^+^ cells (i.e., *Irs1/2* null cells), we found that both models exhibited significantly reduced percentages of Lin^−^YFP^+^ *Irs1/2* null cells ([Figures S3](#app2){ref-type="sec"}C and S3D), suggesting a growth defect of *Irs1/2* double-knockout MECs. In particular, in the *K14-Cre* model, which induced *Irs1/2*-loss in a lot more basal cells than the *MMTV-Cre* model, disruption of IGF/IRS signaling dramatically reduced the percentage of Lin^−^YFP^+^ basal cells ([Figures S3](#app2){ref-type="sec"}C and S3E), suggesting that the basal lineage may be more dependent on this pathway for its survival and/or proliferation than luminal cells. However, since both *K14* and *MMTV* promoters are also active during embryonic development, one cannot differentiate the effects of *Irs1/2* loss on embryonic MEC development from those of adult MEC maintenance by using conventional *K14-Cre* or *MMTV-Cre* mice.

To determine whether IGF/IRS signaling is required for maintenance of each MEC lineage in adults, we injected *Ad-K8-nlsCre* or *Ad-K14-nlsCre* into adult *Irs1*^*L/L*^*;Irs2*^*L/L*^*;R26YFP* nulliparous females. Three days after injection, we found that the *Irs1*^*L/L*^*;Irs2*^*L/L*^*;R26YFP* mice showed similar YFP-labeling efficiencies compared with *R26YFP*-only control females ([Figures 3](#fig3){ref-type="fig"}A and 3B). However, 3 weeks after injection, whereas a similar level of YFP^+^ cells (compared with the initial labeling) could be detected in *R26YFP* control females, in *Irs1*^*L/L*^*;Irs2*^*L/L*^*;R26YFP* females, the percentages of YFP^+^ cells induced by either *Ad-K8-nlsCre* or *Ad-K14-nlsCre* injection decreased significantly ([Figures 3](#fig3){ref-type="fig"}A--3C). These data suggest that IGF/IRS signaling is also essential for maintaining the homeostasis of both the luminal and basal lineages in adult MGs. We also noted that *Ad-K14-nlsCre-*labeled YFP^+^ basal cells almost completely disappeared after 3 weeks ([Figure 3](#fig3){ref-type="fig"}C, compare red circle in p with those in l and n), whereas a few *Ad-K14-nlsCre-*labeled or *Ad-K8-nlsCre-*labeled YFP^+^ luminal cells were still present after a 3-week chase ([Figure 3](#fig3){ref-type="fig"}C, compare green circles in h or p with those in d and f, or in l and n, respectively). These data agree with our findings from the *K14-Cre* and *MMTV-Cre* conditional knockout mice, and suggest that basal cells are more sensitive to loss of IGF/IRS signaling and that this pathway is essential for maintaining the basal lineage in vivo. Taken together, these results show that the lineage-specific *Ad-Cre* system enabled us to quickly study the functions and interactions of different genes and signaling pathways in a cell-autonomous manner.

Studying the Cellular Origin of Mammary Tumors by Using Lineage-Specific *Ad-Cre* {#sec2.4}
---------------------------------------------------------------------------------

Since [@bib22] were able to initiate small cell lung cancer using *Ad-Cre*, we hypothesized that our cell-lineage-specific *Ad-Cre* viruses would allow us to study the cellular origin and transformation process of mammary tumorigenesis. To test this, we injected *Ad-K8-nlsCre* into the mammary ducts of mice carrying the *Etv6-NTRK3* (*EN*) conditional knockin allele we generated previously ([@bib13]). *EN* fusion oncogene, a product from t(12;15)(p13;q25) chromosome translocation, produces a chimeric tyrosine kinase that is characteristic of human secretory breast carcinoma ([@bib23]). Previously, commonly used MEC-specific Cre-expressing mouse lines, including *MMTV-Cre*, *K14-Cre*, and *Wap-Cre*, were applied to activate *EN* expression. However, due to activity outside of the MGs, *MMTV-Cre* or *K14-Cre-*driven *EN* activation led to animal lethality before any mammary tumor developed. Only *Wap-Cre* successfully induced activation of *EN* in alveolar progenitors in MGs, leading to the development of mammary tumors with 100% penetrance ([@bib13]).

We utilized *Ad-K8-nlsCre* for tumor induction in *EN*/+ females through intraductal injection. In all injected *EN*/+ mice, we did not detect any complication or malignancy in other tissues outside of the MG, including skin surrounding the injected nipple area. All injected *EN*/+ females developed multifocal mammary tumors in the injected glands with a tumor-free latency similar to that observed in *Wap-Cre;EN* females ([Figure 4](#fig4){ref-type="fig"}A). Cre-mediated activation of the *EN* knockin allele (i.e., removal of a floxed *Stopper* cassette) was confirmed by PCR using tumor genomic DNA ([Figures 4](#fig4){ref-type="fig"}B and [S4](#app2){ref-type="sec"}A), suggesting that the development of mammary tumors was indeed driven by EN. IF staining of the induced tumors for K8 and K14 showed that two tumor types that developed in the previous *Wap-Cre;EN* model ([@bib13]) were recapitulated in the injected females, including type 1 tumors composed of K8^+^ luminal tumor cells surrounded by K14^+^K5^+^ basal tumor cells ("bilineage," 7 out of 14 tumors), and a type 2 less differentiated tumor comprised of K8^+^K14^+^K5^−^ cells ("double positive," 1 out of 14) ([Figures 4](#fig4){ref-type="fig"}C and [S4](#app2){ref-type="sec"}B). Interestingly, in the injected females, a new type of tumor (type 3 "luminal," 6 out of 14; [Figures 4](#fig4){ref-type="fig"}C and [S4](#app2){ref-type="sec"}B) consisting of predominantly K8^+^K14^−^K5^−^ luminal tumor cells was also detected. All of these tumors were negative or weakly positive (e.g., type 1) for estrogen receptor ([Figure S4](#app2){ref-type="sec"}B).

In virgin females, *Wap-Cre* (either from the transgenic mouse or via adenovirus) labeled a population of preexisting unipotent luminal stem or long-lived progenitor cells committed to the alveolar fate, and intraductal injection of *Wap-Cre* adenovirus into *EN*/+ females led to the development of type 1 and type 2 mammary tumors identical to those in *Wap-Cre;EN* females (M.P.A.v.B., L.T., and Z.L., unpublished data). As K8 is a pan-luminal marker, *Ad-K8-nlsCre* is expected to mark not only *Wap-Cre-*labeled alveolar luminal stem/progenitor cells but also other luminal cell types. Thus, our *Ad-Cre-*based tumor study suggests that EN oncoprotein is capable of transforming multiple luminal MEC subsets. Furthermore, due to the short latency of EN-induced mammary tumorigenesis ([Figure 4](#fig4){ref-type="fig"}A), our data are consistent with a model in which multiple subpopulations of luminal cells can serve as cells of origin, and distinct cellular origins contribute to the heterogeneity of breast cancer.

Experimental Procedures {#sec3}
=======================

Adenovirus Shuttle Vector Construction and Adenovirus Production {#sec3.1}
----------------------------------------------------------------

*Ad-CMV-Cre*, *Ad-CMV-GFP*, promoterless adenoviral shuttle vector (pacAd5 K-NpA), and the packaging vector \[pAd5(9.2-100)sub360\] were obtained from the Gene Transfer Core of the University of Iowa ([@bib1]). nlsCre was amplified from pHR-CMV-nlsCRE plasmid (Addgene). Mouse *K8* promoter was amplified from mouse genomic DNA. Human *K14* promoter was amplified from K14-luciferase plasmid ([@bib21]). Crude *Ad-K8-nlsCre* and *Ad-K14-nlsCre* were purified using the Adenopure purification kit (Puresyn).

Mice {#sec3.2}
----

*R26YFP* and *MMTV-Cre* mice were purchased from The Jackson Laboratory. *K14-Cre* and *Wap-Cre* mice were obtained from the MMHCC Repository. *Etv6-NTRK3* (*EN*) conditional knockin mice, as well as *Irs1* and *Irs2* conditional knockout mice, were described previously ([@bib7; @bib13]). Adenoviruses were introduced into their mammary ducts via intraductal injection. All studies involving mice were approved by our institutional animal care and use committee, and performed in accordance with the relevant protocol.

MEC Preparation, Flow Cytometry, and Sorting {#sec3.3}
--------------------------------------------

Single-cell suspensions of MECs were prepared as previously described ([@bib20]). After antibody staining, flow-cytometric analysis was performed on Accuri 6 and DXP11 flow cytometers. Cell sorting was performed on a BD Aria.

Immunostaining and Clonal Analysis {#sec3.4}
----------------------------------

Mammary tissues were fixed in 10% buffered formalin (Fisher), embedded in paraffin, and sectioned. IF and immunohistochemistry staining were performed on 6 μm paraffin sections for the indicated antibodies by standard procedures. Clonal analysis was performed on MG sagittal sections stained with YFP, K8, and K14 antibodies.

Statistical Analysis {#sec3.5}
--------------------

A Student's t test was used for statistical analysis. Data were reported as mean ± SEM.
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![Genetic Marking of MECs by Intraductal Injection of *Ad-Cre*\
(A and B) Intraductal injection of trypan blue dye into adult (A) and 3-week-old (B) female mice.\
(C) Schematic diagram of *R26YFP* reporter activation upon Cre-mediated excision of a floxed *Stopper* (Stop) cassette.\
(D) Schematic diagram of lineage-tracing strategy using intraductal injection of *Ad-Cre*. Green star designates a YFP-marked stem cell; other green cells refer to more differentiated MECs.\
(E) Different efficiencies of Cre-mediated recombination (measured as % YFP^+^ cells) achieved by using different titers of *Ad-CMV-Cre*.\
(F) Flow-cytometric analysis of *R26YFP* females 3 days after *Ad-CMV-Cre* intraductal injection. Luminal cells (Lu), including luminal progenitors (LP) and mature luminal cells (ML), and basal/myoepithelial cells (Ba), including mammary stem cells (MaSCs), can be labeled by YFP upon *Ad-Cre* induction. Very few stromal cells (S) were labeled by this approach.\
(G) Intraductal injection of *Ad-CMV-GFP* into FVB mice showing transient GFP expression in MGs. In (E) and (G), n = 3 (injected MGs). Data were reported as mean ± SEM.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![MEC Lineage Tracing Using Cell-Type-Specific *Ad-Cre* Lines\
(A) *Ad-K8-nlsCre* specifically labeled luminal epithelial cells (Lu), including mature luminal cells (ML) and luminal progenitors (LP), 3 days (a--d) and 1.5 months (e--h) after injection.\
(B) *Ad-K14-nlsCre-*labeled cells were mostly basal/myoepithelial cells (Ba, including MaSC) 3 days (a--d) and 1.5 months (e--h) after injection. A small portion of luminal cells were also labeled by *Ad-K14-nlsCre*.\
(C--G) IF staining of MGs after various chase durations for YFP^+^ MECs upon pulse labeling by *Ad-Cre* injection at the nulliparous stage.\
(C) Nulliparous MG 3 weeks after *Ad-K8-nlsCre* injection.\
(D) Midgestation MG after *Ad-K8-nlsCre* injection. *Ad-K8-nlsCre-*induced YFP^+^ cells contributed to alveolar formation.\
(E) Nulliparous MG 3 weeks after *Ad-K14-nlsCre* injection.\
(F and G) Midgestation MGs after *Ad-K14-nlsCre* injection. *Ad-K14-nlsCre-*induced YFP^+^ cells contributed to alveolar myoepithelial cells (F) and both ductal and alveolar luminal cells (G). Scale bars, 50 μm.\
(H) YFP-marked multicell clones (at least three cells per clone) induced by *Ad-K14-nlsCre* subdivided based on K8 and K14 expression patterns were quantified as K8-only clones, K14-only clones, or mixed clones.\
See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![IRS1 and IRS2 Are Essential for Maintaining the Basal Lineage\
(A and B) Bar graphs showing the percentages of YFP^+^ cells. *Irs1*^*L/L*^*;Irs2*^*L/L*^*;R26YFP* (IRS-KO) and *R26YFP*-only (WT) control females were injected with *Ad-K8-nlsCre* (A) or *Ad-K14-nlsCre* (B), and YFP^+^ cells were measured by flow cytometry 3 days or 3 weeks after injection. Data were reported as mean ± SEM. n.s., not significant.\
(C) Flow-cytometric analysis of YFP^+^ cells in *Irs1*^*L/L*^*;Irs2*^*L/L*^*;R26YFP* and *R26YFP-*only control females injected with *Ad-K8-nlsCre* (a--h) or *Ad-K14-nlsCre* (i--p). Both luminal cells (compare f and h) and basal/myoepithelial cells (compare n and p) decreased significantly 3 weeks after *Ad-Cre* injection. In particular, in *Ad-K14-nlsCre* injection group (compare n and p), the decrease in YFP^+^ basal/myoepithelial cells was much more profound than that in YFP^+^ luminal cells.\
See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![Tumor Induction Using the *Ad-Cre* Approach\
(A) Kaplan-Meier curves showing mammary tumor development in *EN* knockin virgin female mice injected with *Ad-K8-nlsCre* (n = 9) and in *Wap-Cre;EN* virgin females (n = 10). All mice were under the pure FVB background.\
(B) Cre-mediated activation of the *EN* conditional knockin allele in tumor cells was confirmed by PCR. The locations of the primers used to detect unexcised and excised *EN* alleles are indicated in [Figure S4](#app2){ref-type="sec"}A.\
(C) Three types of tumor derived from *EN/+* mice injected with *Ad-K8-nlsCre* as revealed by K8 and K14 IF staining. Scale bars, 50 μm.\
See also [Figure S4](#app2){ref-type="sec"}.](gr4){#fig4}
